Modern
Parenterals
Parenterals
We are committed to providing trusted medicine to build a portfolio of products that is strategically flexible and adaptive to the market. In our day-to-day work, we focus on the following values while upholding the highest ethical standards.
We offer an extensive range of branded and generic formulations, in compliance with international and national regulations, that cater to diverse therapeutic segments. A broad portfolio of essential hospital products, including sterile IV solutions, infusion systems and devices, parenteral nutrition, anaesthetics, antibiotics.
•Therapeutic Focus •Consumer Leadership •Global Reach •Business Excellence •Partnering Performance •Science & Technology •Collaboration has Value •Contract manufacturing
A lover of literature, Raj’s original intention was to become a professor. He was thwarted by a chemistry professor whose mentoring saw other potentials. As a result, Raj started his pharma career interning at Forest Laboratories and was privileged to work with dedicated formulaters. Shortly after on his 22nd birthday, he went on to join Endo Pharmaceuticals as one of the original employees. In over a decade he helped produce groundbreaking new formulations in pain management and transdermal applications, exceeding Endo Pharmaceuticals gross sales over a billion. As the Global Portfolio Officer of a multibillion dollar Japanese conglomerate he oversaw global operations to implement strategic alliances in pharmaceutics, propelling the company into significant growth since his departure. Raj launched Georgetown Pharmaceuticals in flight from Japan in 2013, with a dedicated vision to help his alliances build a basket of specialized products that drive company sales through volume and progressive growth over time.
"Every aspect of the world today – even politics and international relations – is affected by chemistry"
LEARN MOREWe understand that not one approach fits all. We offer flexibility and agility while working in collaboration with our partners to identify the most feasible approach toward deal closure. Our ability to provide fair assessment with quick turnaround times makes us a preferred partner.
